Here are four quick facts:
1. ArthroFuse is a patent-pending allograft designed for the treatment of hammertoe deformities.
2. Current surgical options for hammertoe include screws, staples, pins and intermedulary implants.
3. Bacterin’s new product eliminates the need for externally communicating pins or permanent implants as it is an implant that will remodel over time into the patient’s own bone.
4. Bacterin develops, manufactures and markets biologics products to domestic and international markets.
More articles on devices:
Intelligent Implant Systems receives spine system patent — 5 things to know
Is the Zimmer-Biomet closed merger finally around the corner? 5 things to know
7 trends in the $850M bone graft substitute market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
